Published in BMC Pediatr on June 23, 2004
Diagnosis of human congenital cytomegalovirus infection by amplification of viral DNA from dried blood spots on perinatal cards. J Mol Diagn (2006) 1.23
Congenital cytomegalovirus infection in high-risk Canadian infants: Report of a pilot screening study. Can J Infect Dis Med Microbiol (2010) 0.87
Evaluation of cytomegalovirus (CMV) DNA quantification in dried blood spots: retrospective study of CMV congenital infection. J Clin Microbiol (2007) 0.87
Public health and laboratory considerations regarding newborn screening for congenital cytomegalovirus. J Inherit Metab Dis (2010) 0.77
Infection-Related Focal Segmental Glomerulosclerosis in Children. Biomed Res Int (2016) 0.75
Characteristics and prognosis of hepatic cytomegalovirus infection in children: 10 years of experience at a university hospital in Korea. Korean J Pediatr (2017) 0.75
Detection of cytomegalovirus in urine from newborns by using polymerase chain reaction DNA amplification. J Infect Dis (1988) 4.44
Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med (2001) 3.90
Detection of cytomegalovirus DNA in peripheral blood of patients infected with human immunodeficiency virus. J Infect Dis (1988) 3.52
Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr (1997) 2.93
Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev (2002) 2.86
Rapid detection of human cytomegalovirus DNA in peripheral blood leukocytes of viremic transplant recipients by the polymerase chain reaction. Transplantation (1989) 2.67
Effect of interstrain variation on diagnostic DNA amplification of the cytomegalovirus major immediate-early gene region. J Clin Microbiol (1992) 1.84
Sequence variation within three important cytomegalovirus gene regions in isolates from four different patient populations. J Clin Microbiol (1998) 1.43
Cytomegalovirus DNA detection in Guthrie cards: a powerful tool for diagnosing congenital infection. J Clin Virol (2000) 1.42
Detection of human cytomegalovirus DNA in dried newborn blood filter paper. J Virol Methods (1994) 1.35
Use of the polymerase chain reaction to analyse sequence variation within a major neutralizing epitope of glycoprotein B (gp58) in clinical isolates of human cytomegalovirus. J Gen Virol (1991) 1.34
Evaluation of PCR primers for early diagnosis of cytomegalovirus infection following liver transplantation. J Clin Microbiol (1998) 1.26
Diagnostic and prognostic value of human cytomegalovirus load and IgM antibody in blood of congenitally infected newborns. J Clin Virol (1999) 1.25
Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis (1997) 1.24
Variations in the cytomegalovirus major immediate-early gene found by direct genomic sequencing. J Clin Microbiol (1992) 1.22
Vaccination against cytomegalovirus, the changeling demon. Pediatr Infect Dis J (1999) 1.04
Epidemiology of congenital cytomegalovirus infection: maternal risk factors and molecular analysis of cytomegalovirus strains. Am J Epidemiol (1998) 1.03
Congenital and maternal cytomegalovirus infections in a London population. Br J Obstet Gynaecol (1991) 0.98
Development of a cytomegalovirus vaccine: lessons from recent clinical trials. Expert Opin Biol Ther (2001) 0.96
Symptomatic congenital cytomegalovirus infection after maternal recurrent infection. Pediatr Infect Dis J (1994) 0.81
A nested primer set targeting the cytomegalovirus glycoprotein B gene. J Clin Virol (2002) 0.79
The octamer is the major form of CENP-A nucleosomes at human centromeres. Nat Struct Mol Biol (2013) 1.59
Sphingomyelinases: enzymology and membrane activity. FEBS Lett (2002) 1.49
Biophysics of sphingolipids I. Membrane properties of sphingosine, ceramides and other simple sphingolipids. Biochim Biophys Acta (2006) 1.44
Giant unilamellar vesicles electroformed from native membranes and organic lipid mixtures under physiological conditions. Biophys J (2007) 1.42
Detergent-resistant, ceramide-enriched domains in sphingomyelin/ceramide bilayers. Biophys J (2005) 1.30
Effects of ceramide and other simple sphingolipids on membrane lateral structure. Biochim Biophys Acta (2008) 1.30
Phase diagrams of lipid mixtures relevant to the study of membrane rafts. Biochim Biophys Acta (2008) 1.29
Membrane restructuring via ceramide results in enhanced solute efflux. J Biol Chem (2002) 1.24
Transbilayer (flip-flop) lipid motion and lipid scrambling in membranes. FEBS Lett (2009) 1.16
Asymmetric addition of ceramides but not dihydroceramides promotes transbilayer (flip-flop) lipid motion in membranes. Biophys J (2004) 1.15
Independent centromere formation in a capricious, gene-free domain of chromosome 13q21 in Old World monkeys and pigs. Genome Biol (2006) 1.13
Modulation of PI-specific phospholipase C by membrane curvature and molecular order. Biochemistry (2005) 1.10
Different effects of long- and short-chain ceramides on the gel-fluid and lamellar-hexagonal transitions of phospholipids: a calorimetric, NMR, and x-ray diffraction study. Biophys J (2005) 1.10
Cholesterol displacement by ceramide in sphingomyelin-containing liquid-ordered domains, and generation of gel regions in giant lipidic vesicles. FEBS Lett (2008) 1.08
Sphingomyelinase activity causes transbilayer lipid translocation in model and cell membranes. J Biol Chem (2003) 1.05
Formation of novel CENP-A domains on tandem repetitive DNA and across chromosome breakpoints on human chromosome 8q21 neocentromeres. Chromosoma (2011) 0.99
Molecular associations and surface-active properties of short- and long-N-acyl chain ceramides. Biochim Biophys Acta (2005) 0.99
Membrane organization and ionization behavior of the minor but crucial lipid ceramide-1-phosphate. Biophys J (2008) 0.99
Coexistence of immiscible mixtures of palmitoylsphingomyelin and palmitoylceramide in monolayers and bilayers. Biophys J (2009) 0.98
Sphingosine increases the permeability of model and cell membranes. Biophys J (2006) 0.98
Leakage-free membrane fusion induced by the hydrolytic activity of PlcHR(2), a novel phospholipase C/sphingomyelinase from Pseudomonas aeruginosa. Biochim Biophys Acta (2007) 0.97
Domain formation in sphingomyelin/cholesterol mixed membranes studied by spin-label electron spin resonance spectroscopy. Biochemistry (2005) 0.97
Ceramide-enriched membrane domains in red blood cells and the mechanism of sphingomyelinase-induced hot-cold hemolysis. Biochemistry (2008) 0.94
Detergent solubilization of phosphatidylcholine bilayers in the fluid state: influence of the acyl chain structure. Biochim Biophys Acta (2006) 0.93
Dihydrosphingomyelin impairs HIV-1 infection by rigidifying liquid-ordered membrane domains. Chem Biol (2010) 0.91
Cholesterol displaces palmitoylceramide from its tight packing with palmitoylsphingomyelin in the absence of a liquid-disordered phase. Biophys J (2010) 0.90
Membrane fusion induced by the catalytic activity of a phospholipase C/sphingomyelinase from Listeria monocytogenes. Biochemistry (2004) 0.89
Biophysics (and sociology) of ceramides. Biochem Soc Symp (2005) 0.89
Sphingomyelinase cleavage of sphingomyelin in pure and mixed lipid membranes. Influence of the physical state of the sphingolipid. Chem Phys Lipids (2002) 0.89
Detergent solubilization of lipid bilayers: a balance of driving forces. Trends Biochem Sci (2013) 0.86
Detergent effects on membranes at subsolubilizing concentrations: transmembrane lipid motion, bilayer permeabilization, and vesicle lysis/reassembly are independent phenomena. Langmuir (2010) 0.86
Surface-active properties of the antitumour ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (edelfosine). Biochim Biophys Acta (2007) 0.86
Phospholipases C and sphingomyelinases: Lipids as substrates and modulators of enzyme activity. Prog Lipid Res (2012) 0.86
Implication of ceramide, ceramide 1-phosphate and sphingosine 1-phosphate in tumorigenesis. Transl Oncogenomics (2008) 0.86
Electroformation of giant unilamellar vesicles from native membranes and organic lipid mixtures for the study of lipid domains under physiological ionic-strength conditions. Methods Mol Biol (2010) 0.83
Interaction of phospholipases C and sphingomyelinase with liposomes. Methods Enzymol (2003) 0.83
End-products diacylglycerol and ceramide modulate membrane fusion induced by a phospholipase C/sphingomyelinase from Pseudomonas aeruginosa. Biochim Biophys Acta (2009) 0.83
Lipid bilayers containing sphingomyelins and ceramides of varying N-acyl lengths: a glimpse into sphingolipid complexity. Biochim Biophys Acta (2013) 0.83
Imaging the early stages of phospholipase C/sphingomyelinase activity on vesicles containing coexisting ordered-disordered and gel-fluid domains. J Lipid Res (2011) 0.82
Surfactant effects of chlorpromazine and imipramine on lipid bilayers containing sphingomyelin and cholesterol. J Colloid Interface Sci (2002) 0.82
Combination of the anti-tumour cell ether lipid edelfosine with sterols abolishes haemolytic side effects of the drug. J Chem Biol (2008) 0.82
Triton X-100 partitioning into sphingomyelin bilayers at subsolubilizing detergent concentrations: effect of lipid phase and a comparison with dipalmitoylphosphatidylcholine. Biophys J (2007) 0.82
Lipid bilayers in the gel phase become saturated by triton X-100 at lower surfactant concentrations than those in the fluid phase. Biophys J (2012) 0.82
Ceramide-induced transbilayer (flip-flop) lipid movement in membranes. Methods Mol Biol (2009) 0.81
Unexpected wide substrate specificity of C. perfringens α-toxin phospholipase C. Biochim Biophys Acta (2011) 0.80
Effects of bilayer composition and physical properties on the phospholipase C and sphingomyelinase activities of Clostridium perfringens α-toxin. Biochim Biophys Acta (2010) 0.80
Multiple phospholipid substrates of phospholipase C/sphingomyelinase HR2 from Pseudomonas aeruginosa. Chem Phys Lipids (2010) 0.80
Accumulated bending energy elicits neutral sphingomyelinase activity in human red blood cells. Biophys J (2012) 0.79
Fluorescent polyene ceramide analogues as membrane probes. Langmuir (2015) 0.79
Membrane binding and insertion of the predicted transmembrane domain of human scramblase 1. Biochim Biophys Acta (2013) 0.79
Phospholipase C and sphingomyelinase activities of the Clostridium perfringens alpha-toxin. Chem Phys Lipids (2009) 0.79
Alkanes are not innocuous vehicles for hydrophobic reagents in membrane studies. Chem Phys Lipids (2005) 0.78
Recruitment of a phospholipase C/sphingomyelinase into non-lamellar lipid droplets during hydrolysis of lipid bilayers. Chem Phys Lipids (2012) 0.78
The onset of Triton X-100 solubilization of sphingomyelin/ceramide bilayers: effects of temperature and composition. Chem Phys Lipids (2013) 0.78
Sphingosine-1-phosphate as an amphipathic metabolite: its properties in aqueous and membrane environments. Biophys J (2009) 0.78
Calcium inhibits diacylglycerol uptake by serum albumin. Biochim Biophys Acta (2008) 0.77
In situ synthesis of fluorescent membrane lipids (ceramides) using click chemistry. J Chem Biol (2012) 0.77
Quantitation of cholesterol incorporation into extruded lipid bilayers. Biochim Biophys Acta (2010) 0.76
A topical microemulsion for the prevention of allergic rhinitis symptoms: results of a randomized, controlled, double-blind, parallel group, multicentre, multinational clinical trial (Nares study). Allergy Asthma Clin Immunol (2013) 0.75
Phosphorylation of glycosyl-phosphatidylinositol by phosphatidylinositol 3-kinase changes its properties as a substrate for phospholipases. FEBS Lett (2005) 0.75